Wednesday, February 04, 2026 | 03:40 AM ISTहिंदी में पढें
Prescription Drug Humira
Biosimilar Humira likely to boost US revenues for Biocon Biologics
Analysts, however, feel that together with upcoming Aspart (insulin) and vaccines, Hulio will help drive BBL's revenues from the current $1 billion to around $1.65 billion by FY25
 "Biosimilar Humira likely to boost US revenues for Biocon Biologics")
Updated On : 04 Jul 2023 | 8:59 PM IST
Humira's best-selling drug formula: Start at high price
Pharma bosses probably miss Martin Shkreli, the reigning villain of the industry
 "Humira's best-selling drug formula: Start at high price")
Updated On : 08 Jan 2018 | 3:52 AM IST